Results 111 to 120 of about 9,191 (168)

3D-Printed Gastroretentive Floating Modified-Release Device for Dual Cardiovascular Drug Delivery: Isosorbide Dinitrate and Hydralazine. [PDF]

Pharmaceutics
Jaiseri D, Pengnam S, Opanasopit P, Suriyaamporn P, Pornpitchanarong C, Rojanarata T, Pamornpathomkul B, Patrojanasophon P, Kansom T, Charoenying T.   +9 more
europepmc   +1 more source

Underuse of hydralazine and isosorbide dinitrate for heart failure in patients of African ancestry: a cross-European survey. [PDF]

ESC Heart Fail, 2019
Brewster LM.
europepmc   +1 more source

Synthesis and Characterization of a Novel Cassava Starch-Based Scaffold Biofunctionalized with Decellularized Extracellular Matrix and Isosorbide Dinitrate. [PDF]

Polymers (Basel)
Cabo-Araoz SD, Cerda-Cristerna BI, Escobar-García DM, Gutiérrez-Hernández JM, Gutiérrez-Sánchez M, Pozos-Guillén A, Flores H.   +6 more
europepmc   +1 more source

Synthesis, characterization of poly L(+) lactic acid and its application in sustained release of isosorbide dinitrate. [PDF]

Sci Rep
Kenawy ER, Abd El Hay AM, Saad N, Azaam MM, Shoueir KR.   +4 more
europepmc   +1 more source

Retracted: Cardioprotective Effect of Isosorbide Dinitrate Postconditioning Against Rat Myocardial Ischemia-Reperfusion Injury In Vivo. [PDF]

Med Sci Monit, 2019
Zhao X, Wang M, Li M, Wu N, Song D.
europepmc   +1 more source

Intraoperative venesection and isosorbide dinitrate for postreperfusion syndrome during liver transplantation: A case report. [PDF]

Medicine (Baltimore), 2018
Kim JH, Kim JH, Lee HJ.
europepmc   +1 more source

Isosorbide DiNitrate Effect on Hemodynamic Profile, Liver Stiffness, and Exercise Tolerance in Fontan Circulation (The NEET Clinical Trial). [PDF]

Pediatr Cardiol
Bigelow AM, Riggs KW, Morales DLS, Opotowsky AR, Lubert AM, Dillman JR, Veldtman GR, Heydarian HC, Trout AT, Cooper DS, Goldstein SL, Chin C, Palermo JJ, Ollberding NJ, Mays WA, Alsaied T.   +15 more
europepmc   +1 more source

The DANish randomized, double-blind, placebo controlled trial in patients with chronic HEART failure (DANHEART): A 2 × 2 factorial trial of hydralazine-isosorbide dinitrate in patients with chronic heart failure (H-HeFT) and metformin in patients with chronic heart failure and diabetes or prediabetes (Met-HeFT). [PDF]

Am Heart J, 2021
Wiggers H, Køber L, Gislason G, Schou M, Poulsen MK, Vraa S, Nielsen OW, Bruun NE, Nørrelund H, Hollingdal M, Barasa A, Bøttcher M, Dodt K, Hansen VB, Nielsen G, Knudsen AS, Lomholdt J, Mikkelsen KV, Jonczy B, Brønnum-Schou J, Poenaru MP, Abdulla J, Raymond I, Mahboubi K, Sillesen K, Serup-Hansen K, Madsen JS, Kristensen SL, Larsen AH, Bøtker HE, Torp-Petersen C, Eiskjær H, Møller J, Hassager C, Steffensen FH, Bibby BM, Refsgaard J, Høfsten DE, Mellemkjær S, Gustafsson F.   +39 more
europepmc   +1 more source

Prevention of contrast-induced nephropathy by adequate hydration combined with isosorbide dinitrate for patients with renal insufficiency and congestive heart failure. [PDF]

Clin Cardiol, 2019
Qian G, Liu CF, Guo J, Dong W, Wang J, Chen Y.   +5 more
europepmc   +1 more source

Clinical Effectiveness of Hydralazine-Isosorbide Dinitrate in African-American Patients With Heart Failure. [PDF]

JACC Heart Fail, 2017
Ziaeian B, Fonarow GC, Heidenreich PA.
europepmc   +1 more source